Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from TNF Pharmaceuticals ( (TNFA) ) is now available.
On March 6, 2025, TNF Pharmaceuticals held a telephonic conference call to discuss the progress of their lead compound, Isomyosamine. The company provided updates on their research and development efforts, but emphasized that the information shared is not necessarily material or required to be disclosed under regulatory obligations.
More about TNF Pharmaceuticals
TNF Pharmaceuticals, Inc. operates in the pharmaceutical industry, focusing on the research and development of medical compounds, with a primary emphasis on their lead compound, Isomyosamine.
YTD Price Performance: -67.83%
Average Trading Volume: 537,931
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.02M
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.